VolitionRX Ltd (NYSE American:VNRX)

2.30
Delayed Data
As of Jun 18
 -0.10 / -4.17%
Today’s Change
1.85
Today|||52-Week Range
4.00
-21.77%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$64.3M

Company Description

VolitionRX Ltd. engages in the development of blood-based cancer tests. Its product Nu.Q is a colorectal cancer screening triage test. The company was founded on August 5, 2010 and is headquartered in Singapore.

Contact Information

VolitionRX Ltd.
1 Scotts Road
Singapore Central Singapore 228208
P:
Investor Relations:
(646) 650-1351

Employees

Shareholders

Individual stakeholders19.98%
Other institutional17.49%
Mutual fund holders1.73%

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
David Vanston CecilChief Financial Officer & Treasurer
Jason Bradley TerrellChief Medical Officer & Head-US Operations
Jacob Vincent MicallefChief Scientific Officer
Louise DayChief Marketing & Communications Officer